The RING finger Protein11 binds to Smad4 and enhances Smad4-dependant TGF-β signalling

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2253-2263

  Azmi, Peter B ^b   Seth, Arun K ^a  

^a Sunnybrook Health Sciences Centre   (Canada)

^b NONE

Author keywords

Breast cancer; RNF11; Signal transduction; Smad4; TGF ; Ubiquitination

Indexed keywords

RING FINGER PROTEIN; RING FINGER PROTEIN 11; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA TRANSFECTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN;

EID: 67650908911     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J and Klippel A: Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Oncogene 22: 6748-6763, 2003.
2. Goumans MJ and Mummery C: Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44: 253-265, 2000. (Pubitemid 30368069)
3. Das P, Maduzia LL and Padgett RW: Genetic approaches to TGFbeta signaling pathways. Cytokine Growth Factor Rev 10: 179-186, 1999. (Pubitemid 30041398)
4. Lutz M and Knaus P: Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 14: 977-988, 2002. (Pubitemid 35279422)
5. Subramaniam V, Li H, Wong M, Kitching R, Attisano L, Wrana J, Zubovits J, Burger AM and Seth A: The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer 20: 1538-1544, 2003. (Pubitemid 37386612)
6. Wakefield LM, Piek E and Bottinger EP: TGF-beta signaling in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 6: 67-82, 2001. (Pubitemid 33640647)
7. Rodriguez C, Chen F, Weinberg RA and Lodish HF: Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors. J Biol Chem 270: 15919-15922, 1995.
8. Lagna G, Hata A, Hemmati-Brivanlou A and Massague J: Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383: 832-836, 1996. (Pubitemid 26372668)
9. Moren A, Hellman U, Inada Y, Imamura T, Heldin CH and Moustakas A: Differential ubiquitination defines the functional status of the tumor suppressor Smad4. J Biol Chem 278: 33571-33582, 2003. (Pubitemid 37055811)
10. Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Makita N, Iiri T, Ueda N, Mashima H and Sugano K: Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions. J Biol Chem 279: 8873-8878, 2004. (Pubitemid 38295947)
11. Wrana J and Pawson T: Signal transduction. Mad about SMADs. Nature 388: 28-29, 1997.
12. Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P and Gauthier JM: Functional proteomics mapping of a human signaling pathway. Genome Res 14: 1324-1332, 2004. (Pubitemid 39029229)
13. Azmi P and Seth A: RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation. Eur J Cancer 41: 2549-2560, 2005. (Pubitemid 41541975)
14. Hofmann K and Falquet L: A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem Sci 26: 347-350, 2001. (Pubitemid 32530646)
15. Connor MK, Azmi PB, Subramaniam V, Li H and Seth A: Molecular characterization of ring finger protein 11. Mol Cancer Res 3: 453-461, 2005. (Pubitemid 41232607)
16. Li H and Seth A: An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein. Oncogene 23: 1801-1808, 2004. (Pubitemid 38445405)
17. Kitching R, Wong MJ, Koehler D, Burger AM, Landberg G, Gish G and Seth A: The RING-H2 protein RNF11 is differentially expressed in breast tumours and interacts with HECT-type E3 ligases. Biochim Biophys Acta 1639: 104-112, 2003. (Pubitemid 38366214)
18. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I and Wrana JL: High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307: 1621-1625, 2005. (Pubitemid 40354744)
19. Arteaga CL, Dugger TC and Hurd SD: The multifunctional role of transforming growth factor (TGF)-betas on mammary epithelial cell biology. Breast Cancer Res Treat 38: 49-56, 1996. (Pubitemid 126424913)
20. Benson JR: Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol J: 229-239, 2004. (Pubitemid 38391218)
21. Dumont N and Arteaga CL: Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res 2: 125-132, 2000. (Pubitemid 32223575)
22. Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and Massague J: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA 102:13909-13914, 2005. (Pubitemid 41377677)
23. Kretzschmar M: Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer. Breast Cancer Res 2: 107-115, 2000. (Pubitemid 32223573)
24. Reiss M and Barcellos-Hoff MH: Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res Treat 45: 81-95, 1997. (Pubitemid 27338535)
25. Siegel PM, Shu W, Cardiff RD, Muller WJ and Massague J: Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci USA 100: 8430-8435, 2003. (Pubitemid 36842562)
26. Deckers M, van Dinther M, Buijs J, Que I, Lowik C, van der PG and ten Dijke P: The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66: 2202-2209, 2006. (Pubitemid 43294931)
27. Connor MK and Seth A: A central role for the ring finger protein RNF11 in ubiquitin-mediated proteolysis via interactions with E2s and E3s. Oncogene 23: 2089-2095, 2004.
28. Hayes S, Chawla A and Corvera S: TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 158: 1239-1249, 2002.
29. Runyan CE, Schnaper HW and Poncelet AC: The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J Biol Chem 280: 8300-8308, 2005. (Pubitemid 40349732)
30. Li Q, Wu L, Oelschlager DK, Wan M, Stockard CR, Grizzle WE, Wang N, Chen H, Sun Y and Cao X: Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells. J Biol Chem 280: 27022-27028, 2005. (Pubitemid 41043225)
31. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK and Reimann JD: The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol 10: 429-439, 2000. (Pubitemid 30682364)
32. Freemont PS: RING for destruction? Curr Biol 10: R84-R87, 2000.
33. Petroski MD and Deshaies RJ: Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9-20, 2005.
34. Ohta T, Michel JJ, Schottelius AJ and Xiong Y: ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol Cell 3: 535-541, 1999. (Pubitemid 29292611)
35. Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K and Wrana JL: TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3: 587-595, 2001.
36. Lin X, Liang M and Feng XH: Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 275: 36818-36822, 2000. (Pubitemid 32002092)
37. Moren A, Imamura T, Miyazono K, Heldin CH and Moustakas A: Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 280: 22115-22123, 2005. (Pubitemid 40827867)
38. Hayes S, Chawla A and Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 158: 1239-1249, 2002.
39. Runyan CE, Schnaper HW and Poncelet AC: The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J Biol Chem 250: 8300-8308, 2005. (Pubitemid 40349732)
40. Moustakas A and Heldin CH: From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction. Genes Dev 16:1867-1871, 2002. (Pubitemid 34832916)